The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated safety, efficacy, pharmacokinetics, and biomarkers from the phase 1 study of IMC-002, a novel anti-CD47 monoclonal antibody, in patients with advanced solid tumors.
 
Ho Yeong Lim
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Eisai; MSD Oncology
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai
Speakers' Bureau - Bayer
 
Jin Seok Ahn
Honoraria - Amgen; AstraZeneca; Bayer; BC World Pharmaceutical; Boehringer Ingelheim; Boryung; Kyowa Kirin; Lilly; Menarini; Nokwon Medical; Novartis; Pfizer; Roche; Samyang; Takeda; Yuhan
Consulting or Advisory Role - Daiichi Sankyo Korea; Guardant Health; ImmuneOncia; Pharmbio Korea; Roche; Therapex; Yuhan
 
Joon Oh Park
Consulting or Advisory Role - ABL Bio; Adicet Bio; Arcus Biosciences; AstraZeneca; Celgene; ImmuneOncia; Intocell; MediRama; Merck Serono; SERVIER
Research Funding - ABL Bio; Celgene; Eutilex; medpacto; SERVIER
Travel, Accommodations, Expenses - Minneamrita Therapeutics
 
Jung Yong Hong
No Relationships to Disclose
 
Sung Young Lee
Employment - Celltrion; Immuneoncia therapeutics inc.
Stock and Other Ownership Interests - Celltrion
 
Haeun Jeong
Employment - ImmuneOncia Therapeutics, Inc.
 
Hwi-yeol Yun
Consulting or Advisory Role - ImmuneOncia Therapeutics, Inc.
 
Seunghwan Shin
Employment - Lunit
 
Chan-Young Ock
Employment - Lunit
Leadership - Lunit
Stock and Other Ownership Interests - Lunit; Y-Biologics
Consulting or Advisory Role - Genome & Company; Idience; Medpacto; PIN therapeutics; Selecxine; Y-Biologics
 
Heung Tae Tae Kim
No Relationships to Disclose